Anheuser-Busch InBev SA/NV (LON:0RJI)
54.46
-0.02 (-0.04%)
At close: Nov 7, 2025
Anheuser-Busch InBev Revenue
Anheuser-Busch InBev had revenue of $15.13B USD in the quarter ending September 30, 2025, with 0.58% growth. This brings the company's revenue in the last twelve months to $58.61B, down -1.34% year-over-year. In the year 2024, Anheuser-Busch InBev had annual revenue of $59.77B with 0.65% growth.
Revenue (ttm)
$58.61B
Revenue Growth
-1.34%
P/S Ratio
2.15
Revenue / Employee
$407.30K
Employees
143,885
Market Cap
93.52B GBP
Revenue Chart
* This company reports financials in USD.
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 59.77B | 388.00M | 0.65% |
| Dec 31, 2023 | 59.38B | 1.59B | 2.76% |
| Dec 31, 2022 | 57.79B | 3.48B | 6.41% |
| Dec 31, 2021 | 54.30B | 7.42B | 15.83% |
| Dec 31, 2020 | 46.88B | -5.45B | -10.41% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Shell | 200.18B |
| BP p.l.c. | 138.32B |
| Unilever | 51.24B |
| AstraZeneca | 43.24B |
| HSBC Holdings | 43.13B |
| Rio Tinto Group | 39.22B |
| GSK plc | 32.17B |
| British American Tobacco p.l.c. | 25.60B |